Samaneh Kahkesh, Seyedeh Mahdieh Khoshnazar, Yasaman Gholinezhad, Shakiba Esmailzadeh, Seyed Ali Hosseini, Mina Alimohammadi, Alireza Mafi
Non-small cell lung cancer (NSCLC), accounting for more than 80% of all cases, is the predominant form of lung cancer and the leading cause of cancer-related deaths worldwide. Significant progress has been made in diagnostic techniques, surgical interventions, chemotherapy protocols, and targeted therapies at the molecular level, leading to enhanced treatment outcomes in patients with NSCLC. Extensive evidence supports the use of circular RNAs (circRNAs), a specific category of naturally occurring non-coding small RNAs (ncRNAs), for the diagnosis, monitoring of treatment efficacy, and assessment of survival in NSCLC...
April 16, 2024: Pathology, Research and Practice